SHS-related disease | From NRHS | From sensitivity analysis 1 | From sensitivity analysis 2 | From sensitivity analysis 3 | ||||
---|---|---|---|---|---|---|---|---|
Cost attributable to SHS exposure ($ million) | Cost attributable to SHS exposure ($ million) | Cost attributable to SHS exposure ($ million) | Using the relative risk (95% CI) for US population | Cost attributable to SHS exposure ($ million) | Using published disease rates for the Chinese population (%) | Cost attributable to SHS exposure ($ million) | ||
Lower bound of RR | Upper bound of RR | Female | Male | |||||
Outpatient | ||||||||
Asthma | 42.9 | 11.7 | 68.4 | 1.97 (1.19 to 3.25)10 | 1.97 (1.19 to 3.25)10 | 42.9 | 0.1619 | 44.6 |
Breast cancer | 40.2 | 0 | 68.8 | 1.68 (1.31 to 2.15)6 | NA | 44.0 | 0.2120 | 281.3 |
Heart disease | 423.6 | 266.5 | 581.0 | 1.50 (1.04 to 1.60)5 | 1.50 (1.04 to 1.60)5 | 790.1 | 0.7719 | 108.1 |
Lung cancer | 1.7 | 0.7 | 2.6 | 1.29 (1.04 to 1.60)6 | 1.29 (1.04 to 1.60)6 | 3.5 | 0.0421 | 2.3 |
TB | 50.6 | 1.2 | 97.8 | 2.33 (1.97 to 2.75)19 | 2.33 (1.97 to 2.75)19 | 94.8 | 0.0822 | 25.7 |
Subtotal | 559.0 | 280.1 | 818.6 | 975.3 | 462.0 | |||
Inpatient | ||||||||
Asthma | 43.4 | 11.1 | 73.3 | 1.97 (1.19, 3.25)10 | 1.97 (1.19 to 3.25)10 | 43.4 | 0.1619 | 111.1 |
Breast cancer | 0.0 | 0 | 0 | 1.68 (1.31 to 2.15)6 | NA | 0.0 | 0.2120 | 0.0 |
Heart disease | 458.7 | 279.9 | 637.7 | 1.50 (1.04 to 1.60)5 | 1.50 (1.04 to 1.60)5 | 867.6 | 0.7719 | 447.5 |
Lung cancer | 0.0 | 0 | 0 | 1.29 (1.04 to 1.60)6 | 1.29 (1.04 to 1.60)6 | 0.0 | 0.0421 | 0.0 |
TB | 110.3 | 2.6 | 210.9 | 2.33 (1.97 to 2.75)18 | 2.33 (1.97 to 2.75)18 | 204.5 | 0.0822 | 200.8 |
Subtotal | 612.4 | 293.5 | 921.9 | 1115.5 | 759.3 | |||
Total | 1171.4 | 573.6 | 1740.0 | 2090.8 | 1221.4 |
NA, not applicable; NRHS, National Rural Household Survey; RR, relative risk; TB, tuberculosis.